Microbot Medical - AI Stock Analysis

Analysis generated November 28, 2025

Microbot Medical Inc. is a medical device company that focuses on the research, development, and commercialization of transformational micro-robotic medical technologies. The company's key areas of focus include endoluminal robotics, which is the development of micro-robotics to enhance treatment and diagnosis procedures. With innovative offerings like the LIBERTY Robotic system, Microbot Medical aims to revolutionize medical treatment, delivering minimally invasive solutions for complex procedures.

Fundamental Analysis

During the last quarter, Microbot Medical reported a revenue of $0. This value matches the revenue reported in the previous quarter, and shows stability with no fluctuations in the revenue figures. Additionally, this is consistent with the revenue from the same quarter last year, which indicates stability over time.

The net income for the most recent quarter was an impressive $280,000. This marks a significant increase of 108.11% compared to the previous quarter—a positive indicator of profitability growth. When compared to the same quarter last year, the increase is even more pronounced at 108.83%, reflecting substantial year-over-year growth.

Moreover, the EBITDA for the last quarter was $290,000, which represents a growth of 108.43% compared to the previous quarter. This upward trend is a strong indicator of an overall improvement in the company’s operating performance. Year-over-year, the EBITDA has risen by 108.97%, a clear sign of improving operational efficiency.

Technical Analysis

Currently, the stock price for Microbot Medical is $2.46. This price reflects a robust increase of 12.33% from a month ago, suggesting positive short-term momentum. When looking at the long-term trend, the stock price has skyrocketed by 153.61% compared to a year ago, demonstrating a strong upward trajectory in the market.

The current 10-day simple moving average (SMA10) stands at $2.00, which is higher than the previous SMA10 of $1.95. This suggests potential upward momentum in the stock's price movements. Additionally, the Relative Strength Index (RSI) is at 57.1, indicating a neutral condition where the stock is neither overbought nor oversold.

Alternative Data Analysis

Starting with job postings and employee sentiment, Microbot Medical currently has 4 open positions as per the most popular job boards. This number has remained constant in the last couple of months, indicating a stable hiring environment and a company potentially looking to expand.

Regarding customer acquisition, Microbot Medical's website has seen an estimated 7,000 visitors, a 75% increase over recent months. This bullish trend suggests growing interest in the company's offerings, which could translate into increased customer acquisition and sales.

In terms of customer engagement, the company’s Instagram page boasts 280 followers, reflecting a 42% increase in the last couple of months. Similarly, their Twitter account has 1,600 followers, up by 18% over the same period. This surge in social media followers indicates a growing interest and positive sentiment toward the company.

AltIndex's AI score, which predicts a company's stock price based on fundamental, technical, and alternative data analysis, rates Microbot Medical with an AI score of 69, categorizing it as a buy signal.

Conclusion and Recommendation

Microbot Medical displays several promising indicators for investors. The company maintains stable revenue levels accompanied by significant growth in net income and EBITDA, which are positive indicators of financial health and operational efficiency. Technical analysis reveals a bullish trend, with a substantial increase in stock price over both the short-term and long-term. Furthermore, the alternative data analysis suggests an inflow of customer interest and engagement, reflected in rising website visitors and social media followers.

Based on the overall analysis presented, Microbot Medical could potentially be a strong investment opportunity. However, as with any investment, potential investors should consider their risk tolerance and investment horizon before making a decision.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.